|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 33/02 | (2006.01) |
| (11) | Number of the document | 3083627 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14825046.7 |
| Date of filing the European patent application | 2014-12-18 | |
| (97) | Date of publication of the European application | 2016-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-05 |
| (46) | Date of publication of the claims translation | 2018-12-27 |
| (86) | Number | PCT/US2014/071077 |
| Date | 2014-12-18 |
| (87) | Number | WO 2015/095477 |
| Date | 2015-06-25 |
| (30) | Number | Date | Country code |
| 201361918089 P | 2013-12-19 | US |
| (72) |
BIGGART, Agnes, US
LIANG, Fang, US
MATHISON, Casey Jacob Nelson, US
MOLTENI, Valentina, US
NAGLE, Advait Suresh, US
SUPEK, Frantisek, US
YEH, Vince, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | [1,2,4]Triazolo[1,5-a]pirimidino dariniai kaip protozoano proteasomos inhibitoriai, skirti parazitinių ligų tokių kaip leišmaniozė, gydymui |
| [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS PROTOZOAN PROTEASOME INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES SUCH AS LEISHMANIASIS |
| Payment date | Validity (years) | Amount | |
| 2022-12-13 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-12-18 |